Patients Give Charleston Oncology High Marks In Patient Satisfaction Surveys

Charleston Oncology received high marks from patients with cancer in surveys conducted by the Community Oncology Alliance (COA), the national organization that advocates for community oncology providers and the patients they serve.

Charleston Oncology, which serves patients with cancer in the Lowcountry, performed strongly in all areas of the survey. The 2020 rankings of the patient experience as reported by actual patients exceeded statewide and national averages. The practice has achieved this ranking every year since the inception of the survey and is ranked amongst the highest in the nation.

COA’s “Oncology Medical Home (OMH) Patient Satisfaction Survey” tracks cancer patient experience and satisfaction nationally, statewide, and by individual practice. With more than 184,000 individual patient surveys completed since launching in 2015, the OMH Patient Satisfaction Survey solicits patient feedback about their care providers and all aspects of treatment, including communication, thoroughness of information given, and staff friendliness and interaction. It is based on the standardized Consumer Assessment of Healthcare Providers and Systems (CAHPS) and uses questions specifically designed for cancer care.

“We are incredibly proud of the high-quality and personal cancer care that is delivered at Charleston Oncology. The OMH Survey feedback enables every member of our team to hear from patients, monitor and improve processes, and ensure excellent patient experiences,” said Dax Arrington, Vice-President/CEO at Charleston Oncology.

“The OMH is a proven model that provides enhanced patient communications, greater care coordination, and increased responsiveness to patient needs by participating in independent, national quality efforts like COA’s Oncology Medical Home (OMH). Charleston Oncology is proving it is dedicated to delivering world-class, patient-centered cancer care,” said Bo Gamble, director of strategic practice initiatives at COA. “We are incredibly proud of the success that the practice has seen in the OMH program which is reflected in these outstanding patient survey results.”

Independent, community oncology practices like Charleston Oncology treat the majority of patients with cancer in America and are committed to improving oncology care for all. This includes leading the development and piloting of the original OMH model, as well as, participating in the Centers for Medicare & Medicaid Services (CMS) Innovation Center's (CMMI) oncology payment and delivery reform initiatives such as the Oncology Care Model (OCM).


About Charleston Oncology: Charleston Oncology provides compassionate and individualized care for cancer patients and their families with a professional and friendly staff. Recognizing that cancer, and its treatments, bring unfortunate side effects, they ensure that every patient is as comfortable as possible.

If you or a loved one is facing a cancer diagnosis, call Charleston Oncology to learn more about the latest, cutting-edge treatments, which are delivered in a local setting. Learn more at

About the Community Oncology Alliance: The majority of Americans battling cancer receive treatment in the community oncology setting. Keeping patients close to their homes, families, and support networks lessens the impact of this devastating disease. Community oncology practices do this while delivering high-quality, cutting-edge cancer care at a fraction of the cost of the hospital setting. The Community Oncology Alliance (COA) advocates for community oncology and smart public policy that ensures the community cancer care system remains healthy and able to provide all Americans with access to local, quality, affordable cancer care. Learn more at

You Might Also Enjoy...

Charleston Oncology National Cancer Survivor Month

June is National Cancer Survivor Month and throughout the month we are honoring our brave patients and sharing their inspirational stories. National Cancer Survivor Month celebrates those who have beat cancer and those who are currently in treatment.